SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Hanesbrands Inc. (HBI) , forward earnings yield 10.18%. PEG 1.18.
Criteria proven by this page:
- VALUE (60/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
- Forward P/E 9.8
- PEG Ratio 1.18 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Analyst consensus target $7.00 (+8.2% upside) — modest upside expected.
Overall SharesGrow Score: 34/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
60/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HBI
Valuation Multiples
P/E (TTM)0.0
Forward P/E9.8
PEG Ratio1.18
Forward PEG1.18
P/B Ratio0.00
P/S Ratio0.65
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.91
Forward EPS (Est.)$0.66
Book Value / Share$0.00
Revenue / Share$9.96
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield10.18%
Dividend Yield0.00%
Analyst Target$7.00 (+8.2%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$1.06 |
$5.73B |
$428.86M |
7.5% |
| 2016 |
$1.40 |
$6.03B |
$539.38M |
8.9% |
| 2017 |
$0.17 |
$6.47B |
$61.89M |
1% |
| 2018 |
$1.52 |
$6.8B |
$553.08M |
8.1% |
| 2019 |
$1.64 |
$6.97B |
$600.72M |
8.6% |
| 2020 |
$-0.21 |
$6.66B |
$-75.58M |
-1.1% |
| 2021 |
$1.48 |
$6.8B |
$520.97M |
7.7% |
| 2022 |
$-0.37 |
$6.23B |
$-131.17M |
-2.1% |
| 2023 |
$-0.05 |
$5.64B |
$-17.73M |
-0.3% |
| 2024 |
$-0.91 |
$3.51B |
$-320.43M |
-9.1% |
